13 Oktober 2020

Amyris Delivering Sustainable Alternative To Shark Squalene Adjuvant – Enabling Vaccines For All With No Sharks Killed

Amyris expects commercialization and production of its alternative squalene for adjuvants in the fourth quarter

Amyris, Inc., a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it is currently delivering samples to pharmaceutical companies of a sustainable and scalable alternative to shark-based vaccine adjuvants currently used in a number of vaccines, including those directed at influenza and COVID-19. Amyris expects commercialization and production of its alternative squalene for adjuvants in the fourth quarter.

Squalene is a natural oil made in the liver of sharks and used as an ingredient within adjuvants in vaccines to improve efficacy of a vaccine.
Shark-based squalene is used in influenza vaccines and in various COVID-19 vaccines.
Amyris has developed a process to naturally produce sugarcane-derived squalene as an effective alternative to shark-derived squalene.

Adjuvants are added to vaccines to boost immune system response and those including squalene are typically sourced from deep-sea shark livers, a non-sustainable and non-scalable resource.

“Our patented technology and manufacturing processes have already produced a number of applications to, among other things, create a scalable treatment for malaria, and a variety of sustainably-sourced clean products and ingredients that are better for people and our planet,” said John Melo, President and CEO. “We believe our capabilities are critical toward supporting a healthier planet while protecting its resources, including the lives of sharks essential to the marine ecosystem. We are committed to delivering the world’s needs for a high performance, low cost sustainable squalene without killing a single shark. We believe this is essential in responding to pandemics and delivering vaccines for all people in need on our planet.”

Source: Amyris, press release, 2020-10-01.

Supplier

Share on Twitter+1Share on FacebookShare on XingShare on LinkedInShare via email